The current diagnostics of hepatic steatosis in pediatric subjects based on US and surrogate indexes need additional improvements, and this can be achieved with a future combination of them in novel algorithms accounting for additional protein markers such as CDH2 and FAP. This evidence concerns the gene CDH2 and Hepatic steatosis.